Psychiatric Consultation Through Videoconference in a Primary Care Setting
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00298961|
Recruitment Status : Unknown
Verified May 2008 by Sha’ar Menashe Mental Health Center.
Recruitment status was: Not yet recruiting
First Posted : March 3, 2006
Last Update Posted : May 21, 2008
|Condition or disease||Intervention/treatment||Phase|
|Remote Consultation Community Psychiatry||Device: Videoconference equipment FALCON/IP||Not Applicable|
Hide Detailed Description
Telepsychiatry, as a method which utilizes videoconferencing as a means for consultation, examination and treatment of patients as a substitute for in-person treatment has been in use now for over 40 years. With telepsychiatry there is an attempt to deal with the issues of providing service to patients who reside at a considerable distance from the mental health facilities or that conversely do not call for mental health services for other diverse reasons such as loss of work days, social stigma, travel expenses and so forth.
In Israel, mental health services are provided to 1.5% of the population whereas the incidence in other developed countries is significantly higher, reaching 3-5%, while the prevalence of mental illness in Israel is similar. One can hypothesize that the above factors such as social stigma, mental health care availability, loss of work days and travel expenses all play a role in this. Consequently, patients may prefer to see their primary care physician as an alternative, and according to reports of the Israeli national health services, 30%-50% of visits to the primary care physician are mental health related. Thanks to the technological advances in telecommunications, especially regarding cost reduction and higher bandwidths, there has been a renewed interest in telepsychiatry. However, the issue of the cost effectiveness of telepsychiatry is still controversial. Out of 380 studies on telepsychiatry published from 1956 to 2002, only 12 dealt with the question of cost effectiveness, and among those the results were equivocal. Another question that has scarcely been studied is that of quality of life within telepsychiatry treatment. Finally, the issue of telepsychiatry that is used as a consultation tool in the aid of the primary physician that occurs physically in his own practice is another novel angle we wish to explore. The advantages embodied in this are potentially many - patient discreteness and confidentiality, decrease in expenses and stigma reduction among others.
In our study we will attempt to address the above issues that have not received the focus of attention in many of the published studies so far - cost analysis and quality of life within the context of telepsychiatry consultation in primary care. Additionally, we will address the issues of clinical efficacy and satisfaction (of the primary care provider as well as that of the patient) from the treatment.
Our study hypotheses are:
- The satisfaction of the patients will increase during the 12 months of study in the group treated by telepsychiatry in comparison with the control groups.
- Cost analysis - the use of telepsychiatry will reduce the costs for the primary health care centers and/or for the mental health centers: Travel expenses, a decrease in visitations to the primary health care center, a decrease in hospitalizations in general hospitals and/or psychiatric hospitals, a decrease in the number of ancillary tests and of lost work days.
- Effectiveness of treatment - the mental and physical well being of the patients will improve or at least not be impaired in the group treated by telepsychiatry as compared to the control groups due to the increased availability of the consultation service.
- The number of patients referred to mental health treatment will be higher than that of the previous year due to the increased availability of telepsychiatry within the primary care setting.
- The patients will prefer the telepsychiatry service as compared to a referral to a mental health center.
- Quality of life will improve or it least not be impaired in the group treated by telepsychiatry as compared to the control groups.
- Stigma reduction - Visitations to the primary health care center as opposed to the mental health center will lower the possibility of the formation of a social stigma of mental disease.
- Telepsychiatry treated patients within the primary care setting.
- In-person treated patients by a psychiatrist at the mental health center.
- Primary care treated patients without a psychiatry consultation.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||160 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Telepsychiatry: Cost Analysis, Quality of Life, Satisfaction and Effectiveness of Psychiatric Consultation Through Videoconference in a Primary Care Setting|
|Study Start Date :||May 2006|
|Estimated Study Completion Date :||November 2007|
- Brief Psychiatric Rating Scale (BPRS) at 0 months, 6 months and 12 months.
- Clinical Global Impression Scale (CGI) at 0 months, 6 months and 12 months.
- Hamilton Anxiety Rating Scale (HAM-A) at 0 months, 6 months and 12 months.
- Hamilton Depression Rating Scale (HAM-D) at 0 months, 6 months and 12 months.
- Global satisfaction questionnaire at 0 months, 6 months and 12 months.
- General Health Questionnaire 11 (GHQ11) at 0 months, 6 months and 12 months.
- Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-18) at 0 months, 6 months and 12 months.
- Costs: Travel expenses, extra consultations, hospitalizations, Medication, loss of work days, medical visitations, ancillary tests such as ECG, lab tests and others at 0 months, 6 months and 12 months.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00298961
|Contact: Mahmud Jabarin, MDemail@example.com|
|Contact: Ehud Susser, MDfirstname.lastname@example.org|
|Sha'ar Menashe Mental Health Center Ambulatory Clinic||Recruiting|
|Hadera, Israel, 38814|
|Contact: Mahmud Jabarin, MD +972-4-6278110 email@example.com|
|Contact: Ehud Susser, MD +972-4-6278946 firstname.lastname@example.org|
|Principal Investigator: Mahmud Jabarin, MD|
|Principal Investigator:||Mahmud Jabarin, MD||Sha'ar Menashe Mental Health Center, Israel|
|Study Chair:||Ilan Modai, MD, MHA||Sha'ar Menashe Mental Health Center, Israel|
|Study Chair:||Ehud Susser, MD||Sha'ar Menashe Mental Health Center, Israel|